Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_assertion type Assertion NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_head.
- NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_assertion description "[In a subset of patients with psoriasis (n=50), the GSTM1 genotype was not associated with PUVA outcomes, although MPD [hazard ratio (HR) 1�37; 95% confidence interval (CI) for HR 1�15-1�64] and GSTT1-null (HR 2�39; 95% CI for HR 1�31-4�35) and GSTP1b (HR 1�96; 95% CI for HR 1�10-3�51) genotypes were associated with clearance of psoriasis in this patient group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_provenance.
- NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_assertion evidence source_evidence_literature NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_provenance.
- NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_assertion SIO_000772 21967523 NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_provenance.
- NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_assertion wasDerivedFrom befree-20150227 NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_provenance.
- NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_assertion wasGeneratedBy ECO_0000203 NP440532.RA9v21fh5yOcq0nGmzoAnkrKdBI90VFUDgszVyfY5l_SU130_provenance.